^
No biomarker
Osteosarcoma
doxorubicin hydrochloride
Sensitive
:
A1
No biomarker
Osteosarcoma
ADX-2191
Sensitive
:
A1
No biomarker
Osteosarcoma
regorafenib
Sensitive
:
A2
No biomarker
Osteosarcoma
IE
Sensitive
:
A2
No biomarker
Osteosarcoma
gemcitabine + docetaxel + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
regorafenib + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
sorafenib + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
carboplatin + etoposide IV + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
carboplatin + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
etoposide IV + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Osteosarcoma
gemcitabine + docetaxel + ifosfamide
Sensitive
:
A2
No biomarker
Osteosarcoma
carboplatin + ifosfamide + etoposide IV
Sensitive
:
A2
No biomarker
Osteosarcoma
carboplatin + ifosfamide
Sensitive
:
A2
No biomarker
Osteosarcoma
cisplatin + ifosfamide + methotrexate + SGN-15
Sensitive
:
A2
No biomarker
Osteosarcoma
cisplatin + ifosfamide + pegylated liposomal doxorubicin
Sensitive
:
A2
No biomarker
Osteosarcoma
ifosfamide + etoposide oral + methotrexate
Sensitive
:
A2
No biomarker
Osteosarcoma
sorafenib + everolimus
Sensitive
:
A2
No biomarker
Osteosarcoma
gemcitabine
Sensitive
:
A2
No biomarker
Osteosarcoma
gemcitabine + docetaxel
Sensitive
:
A2
No biomarker
Osteosarcoma
topotecan + cyclophosphamide intravenous
Sensitive
:
A2
No biomarker
Osteosarcoma
cabozantinib tablet
Sensitive
:
A2
No biomarker
Osteosarcoma
sorafenib
Sensitive
:
A2
No biomarker
Osteosarcoma
ifosfamide
Sensitive
:
A2
No biomarker
Osteosarcoma
cisplatin + SGN-15 + methotrexate IV
Sensitive
:
A2
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our